DNA Topoisomerase IIα in Multiple Myeloma: A Marker of Cell Proliferation and Not Drug Resistance
- 1 September 2001
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (9) , 886-891
- https://doi.org/10.1038/modpathol.3880407
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cell density‐dependent VP‐16 sensitivity of leukaemic cells is accompanied by the translocation of topoisomerase IIα from the nucleus to the cytoplasmBritish Journal of Haematology, 2000
- Decreased CP-1 (NF-Y) Activity Results in Transcriptional Down-Regulation of Topoisomerase IIα in a Doxorubicin-Resistant Variant of Human Multiple Myeloma RPMI 8226Biochemical and Biophysical Research Communications, 1997
- The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissuesBritish Journal of Cancer, 1997
- Glutathione and related enzymes in multidrug resistanceEuropean Journal Of Cancer, 1996
- Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistanceInternational Journal of Cancer, 1996
- GST‐7T and P‐170 co‐expression in multiple myelomaBritish Journal of Haematology, 1995
- Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cellsBritish Journal of Haematology, 1993
- Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myelomaBritish Journal of Cancer, 1992
- Glutathione and glutathione S-transferases in a human plasma cell line resistant to melphalanBiochemical Pharmacology, 1989
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983